260353-64-8

Basic information

• Product Name: Bicyclo[3.1.0]hexane-2,6-dicarboxylic acid, 2-amino-6-fluoro-, (1R,2S,5R,6S)-rel- (9CI)
• Synonyms: Bicyclo[3.1.0]hexane-2,6-dicarboxylic acid, 2-amino-6-fluoro-, (1R,2S,5R,6S)-rel- (9CI)
• CAS NO: 260353-64-8
• Molecular Formula: C8H10FNO4
• Molecular Weight: 203.1677032
• Product Categories: AMINOACID
• Mol File: 260353-64-8.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Bicyclo[3.1.0]hexane-2,6-dicarboxylic acid, 2-amino-6-fluoro-, (1R,2S,5R,6S)-rel- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Bicyclo[3.1.0]hexane-2,6-dicarboxylic acid, 2-amino-6-fluoro-, (1R,2S,5R,6S)-rel- (9CI)(260353-64-8)
• EPA Substance Registry System: Bicyclo[3.1.0]hexane-2,6-dicarboxylic acid, 2-amino-6-fluoro-, (1R,2S,5R,6S)-rel- (9CI)(260353-64-8)

Safety Data

• Hazardous Substances Data: 260353-64-8(Hazardous Substances Data)

Upstream product

• 260353-83-1 (1R,2S,5R,6R)-2-spiro-5'-hydantoin-6-fluorobicyclo[3.1.0]hexane-6-carboxylic acid 
• 321903-57-5 (1S,2R,5S,6S)-2-spiro-5'-hydantoin-6-fluorobicyclo[3.1.0]hexane-6-carboxylic acid 
• 635318-09-1 (1R,2S,5R,6R)-diethyl-2-(2'R-tert-butoxycarbonylamino-propionylamino)-6-fluoro-bicyclo[3.1.0]hexane-2,6-dicarboxylate 
• 635318-21-7 (1S,2R,5S,6S,2'R)-diethyl-2-(2'-tert-butoxycarbonylaminopropionylamino)-6-fluoro-bicyclo[3.1.0]hexane-2,6-dicarboxylate 
• 260353-79-5 ethyl (-)-(1R,5R,6R)-6-fluoro-2-oxobicyclo[3.1.0]hexane-6-carboxylate 
• 321903-56-4 ethyl (+)-(1S,5S,6S)-6-fluoro-2-oxobicyclo[3.1.0]hexane-6-carboxylate 
• 385368-01-4 (1R,5R,6R)-6-Fluoro-2-oxo-bicyclo[3.1.0]hexane-6-carboxylic acid 
• 385368-06-9 (1S,5S,6S)-6-Fluoro-2-oxo-bicyclo[3.1.0]hexane-6-carboxylic acid 

Relevant articles and documents

PRODRUGS OF EXCITATORY AMINO ACIDS

This invention relates to a synthetic excitatory amino acid prodrug and processes for its preparation. The invention further relates to methods of using, and pharmaceutical compositions comprising, the compounds for the treatment of neurological disorders and psychiatric disorders.

PRODRUGS OF EXCITATORY AMINO ACIDS

This invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. The invention further relates to methods of using, and pharmaceutical compositions comprising, the compounds for the treatment of neurological disorder

Synthesis, SARs, and pharmacological characterization of 2-Amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonists

(+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (4, LY354740), a highly selective and orally active group II metabotropic glutamate receptor (mGluR) agonist, has increased interest in the study of group II mGluRs. Our interest focused on a conformat